Ono Pharmaceutical Co., Ltd. (OPHLF)
14.55
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Ono Pharmaceutical EPS Diluted (Quarterly) : 0.0109 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0109 |
| December 31, 2025 | 0.3986 |
| September 30, 2025 | 0.3236 |
| June 30, 2025 | 0.2599 |
| March 31, 2025 | -0.0914 |
| December 31, 2024 | 0.2087 |
| September 30, 2024 | 0.2403 |
| June 30, 2024 | 0.3385 |
| March 31, 2024 | 0.2486 |
| December 31, 2023 | 0.5123 |
| September 30, 2023 | 0.61 |
| June 30, 2023 | 0.4737 |
| March 31, 2023 | 0.2637 |
| December 31, 2022 | 0.4824 |
| September 30, 2022 | 0.4865 |
| June 30, 2022 | 0.4649 |
| March 31, 2022 | 0.2787 |
| December 31, 2021 | 0.3238 |
| September 30, 2021 | 0.4042 |
| June 30, 2021 | 0.4408 |
| March 31, 2021 | 0.1687 |
| December 31, 2020 | 0.5107 |
| September 30, 2020 | 0.3464 |
| June 30, 2020 | 0.4005 |
| March 31, 2020 | 0.1448 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.3503 |
| September 30, 2019 | 0.3049 |
| June 30, 2019 | 0.2896 |
| March 31, 2019 | 0.1484 |
| December 31, 2018 | 0.2464 |
| September 30, 2018 | 0.2374 |
| June 30, 2018 | 0.2715 |
| March 31, 2018 | 0.1588 |
| December 31, 2017 | 0.3485 |
| September 30, 2017 | 0.1647 |
| June 30, 2017 | 0.2007 |
| March 31, 2017 | 0.2213 |
| December 31, 2016 | 0.3334 |
| September 30, 2016 | 0.174 |
| June 30, 2016 | 0.2392 |
| March 31, 2016 | 0.095 |
| December 31, 2015 | 0.1135 |
| September 30, 2015 | 0.0374 |
| June 30, 2015 | 0.1469 |
| March 31, 2015 | -0.0433 |
| December 31, 2014 | 0.2049 |
| September 30, 2014 | 0.0068 |
| June 30, 2014 | 0.0537 |
| March 31, 2014 | 0.0166 |
| December 31, 2013 | 0.1548 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0496 |
| Daiichi Sankyo Co., Ltd. | 0.1472 |
| Eisai Co., Ltd. | -0.0184 |
| Chugai Pharmaceutical Co., Ltd. | 0.2235 |
| Santen Pharmaceutical Co., Ltd. | 0.3043 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 6.635M |
| Revenue (Quarterly) | 756.86M |
| Total Expenses (Quarterly) | 751.64M |
| Enterprise Value | 6.144B |
| Gross Profit Margin (Quarterly) | 72.16% |
| Profit Margin (Quarterly) | 0.88% |
| Earnings Yield | 6.82% |